Abstract P4-02-12: Validation of Profile for the Omission of Local Adjuvant Radiotherapy (POLAR) in early-stage invasive breast cancer patients of the Scottish Conservation Trial

Autor: Karen J. Taylor, John MS Bartlett, John Bennett, S. Laura Chang, Bradley Arrick, Frederick Baehner, Joseph F. Loane, Tammy Piper, Elizabeth Mallon, Joanna Dunlop, Wilma J. Jack, Jacqueline Caldwell, Ian Kunkler, Linda J. Williams, Corey W. Speers, Felix Y. Feng, Lori Pierce, David A. Cameron

Publikováno v: Cancer Research. 83:P4-02

Background: Adjuvant whole breast radiotherapy (RT) is provided to almost all women with early-stage invasive breast cancer after breast conserving surgery and appropriate systemic therapy. While there is increasing interest to personalize the use of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b0c86ac4b2899885aae88d187cd5b5ef
https://doi.org/10.1158/1538-7445.sabcs22-p4-02-12

Abstract P2-16-15: 10-year outcome for women randomized in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: An anglo-celtic cooperative oncology group study

Autor: Helena M. Earl, Robert E. Coleman, Timothy J. Perren, T.R. Jeffry Evans, Janine Mansi, Joanna Dunlop, Chara Stavraka, David Cameron, Robert C. F. Leonard

Publikováno v: Cancer Research. 80:P2-16

Aim: The aim of this study was to compare the long-term outcome of women with primary or locally advanced breast cancer randomised to receive either doxorubicin and cyclophosphamide (AC) or doxorubicin and docetaxel (AD) as primary chemotherapy. Pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::55d97d37f4140fb94d03062e87eb3763
https://doi.org/10.1158/1538-7445.sabcs19-p2-16-15

GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial

Autor: Gianfilippo Bertelli, Robert C. F. Leonard, A. Yellowlees, Robert E. Coleman, Joanna Dunlop, Douglas Adamson, Geraldine A. Thomas, Richard A. Anderson, Janine Mansi

Publikováno v: Leonard, R C F, Adamson, D J A, Bertelli, G, Mansi, J, Yellowlees, A, Dunlop, J, Thomas, G A, Coleman, R E & Anderson, R A 2017, ' GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial ', Annals of Oncology, vol. 28, no. 8, pp. 1811-1816 . https://doi.org/10.1093/annonc/mdx184

Background Chemotherapy-induced premature ovarian insufficiency (POI) impacts fertility and other aspects of women's health. The OPTION trial tested whether administration of a gonadotropin-releasing hormone agonist during chemotherapy for early brea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68ea44fb84e7a642bf22ac308fdfda70
https://hdl.handle.net/20.500.11820/6df4bae5-417a-40f7-a9ce-9d5b3d7db439

Can dynamic changes in prognostic markers predict survival in patients receiving VEGF-targeted therapy in clear cell renal cell carcinoma?

Autor: Paul Nathan, Peter E Hall, Amit Bahl, Duncan McLaren, Andrew Webb, Simon Chowdhury, Scott Thomas Colville Shepherd, T. Geldart, Kate Fife, Robert E. Hawkins, Luis Beltran, Robert Jones, Janet E. Brown, Charlotte Ackerman, Simon J. Crabb, Ekaterini Boleti, James Larkin, Joanna Dunlop, Christy Ralph, Thomas Powles

Publikováno v: Journal of Clinical Oncology. 35:e16061-e16061

e16061 Background: Markers of the systemic inflammatory response have prognostic value in ccRCC prior to starting treatment. Dynamic changes during therapy and their role in predicting prognosis are not well characterised. Methods: A retrospective an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c9c0b25c0cdd21b65877c1cb07aef73d
https://doi.org/10.1200/jco.2017.35.15_suppl.e16061

Treatment resistant gastric antral vascular ectasia in a patient undergoing haemodialysis

Autor: Yeri, Ahn, Tom Kai Ming, Wang, Joanna, Dunlop

Publikováno v: Journal of renal care. 40(4)

Gastric antral vascular ectasia (GAVE) is an important cause of upper gastrointestinal bleeding and has a high prevalence in patients with renal insufficiency. We report the first documented case of a 52-year-old patient on haemodialysis with GAVE re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b81b11ab970e039209e355f6d0fae143
https://pubmed.ncbi.nlm.nih.gov/24965484